NCT04668651

Brief Summary

Gastric aspiration represents the third cause of perioperative death in France. In scheduled surgery, it can be prevented by preoperative fasting. The French and American guidelines recommend a fasting of 2 hours for clear liquids and 6 hours for solid food. However, these durations could be too short in case of delayed gastric emptying due to medications of diabetes for example. This latter condition has an increasing incidence. Numerous complications are related to chronic hyperglycemia including delayed gastric emptying also known as gastroparesis. Around one third of diabetic patients presents this complication. Gastric ultrasound represents a non-invasive method to explore the stomach. It allows the qualitative and quantitative evaluations of gastric content. As diabetic patients present a risk of non-empty stomach despite fasting,investigators decided to conduct a prospective observational study compare the appearance of the stomach assessed by ultrasonography between diabetic and non-diabetic patients before scheduled surgery

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 9, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 16, 2020

Completed
27 days until next milestone

Study Start

First participant enrolled

January 12, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 5, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 5, 2021

Completed
Last Updated

December 3, 2025

Status Verified

November 1, 2025

Enrollment Period

3 months

First QC Date

December 9, 2020

Last Update Submit

November 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Antral content

    Evaluation of antral content according to the Perlas classification (0, 1 or 2) and antral surface area between diabetic and non-diabetic patients.

    Preoperative

Secondary Outcomes (5)

  • Antral area

    Pre-operative, on arrival in the operating room

  • Perlas grades

    Pre-operative, on arrival in the operating room

  • Characteristics of diabetes

    Pre-operative, on arrival in the operating room

  • Clinical signs of diabetic gastroparesis

    Pre-Anesthesia Consultation

  • Perioperative respiratory complications

    Peri-operative

Study Arms (2)

diabetic

diabetic patients

Other: antral ultrasound

non diabetic

non-diabetic patients

Other: antral ultrasound

Interventions

Preoperative evaluation of gastric contents by antral ultrasound

diabeticnon diabetic

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Any treated diabetic and non-diabetic patient requiring elective vascular surgery

You may qualify if:

  • Age \> 18 years old
  • Any treated diabetic and non-diabetic patient requiring elective vascular surgery who has agreed to participate in the study (consent form obtained).
  • Affiliation or beneficiary of social security.

You may not qualify if:

  • Pregnant woman
  • Persons of full age protected by law
  • Patient Refusal
  • Patient deprived of liberty
  • History of gastric surgery
  • Any situation requiring urgent treatment that is not compatible with the performance of a gastric ultrasound scan.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Nice

Nice, PACA, 06000, France

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Jean-Christophe ORBAN

    Centre Hospitalier Universitaire de Nice

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2020

First Posted

December 16, 2020

Study Start

January 12, 2021

Primary Completion

April 5, 2021

Study Completion

April 5, 2021

Last Updated

December 3, 2025

Record last verified: 2025-11

Locations